Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedAug 15, 2026
DataAggregated Company Financials
Companies6
- 7D-2.0%
- 3M-17.0%
- 1Y-39.3%
- YTDn/a
Over the last 7 days, the Drug Retail industry has dropped 2.0%, driven by Alibaba Health Information Technology declining 9.4%. Overall the industry is down 39% in 12 months. Looking forward, earnings are forecast to grow by 15% annually.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 15 Aug 2026 | HK$197.3b | HK$143.9b | HK$8.8b | 29.6x | 22.5x | 1.4x |
| Mon, 13 Jul 2026 | HK$194.5b | HK$143.1b | HK$8.7b | 30.8x | 22.3x | 1.4x |
| Wed, 10 Jun 2026 | HK$196.3b | HK$142.9b | HK$8.7b | 33.4x | 22.6x | 1.4x |
| Fri, 08 May 2026 | HK$247.3b | HK$140.8b | HK$8.7b | 42.4x | 28.6x | 1.8x |
| Sun, 05 Apr 2026 | HK$263.3b | HK$139.4b | HK$8.6b | 46.6x | 30.7x | 1.9x |
| Tue, 03 Mar 2026 | HK$306.8b | HK$130.5b | HK$7.0b | 41x | 43.9x | 2.4x |
| Thu, 29 Jan 2026 | HK$360.3b | HK$128.5b | HK$6.9b | 51x | 52.4x | 2.8x |
| Sat, 27 Dec 2025 | HK$308.4b | HK$126.9b | HK$6.8b | 38.8x | 45.4x | 2.4x |
| Mon, 24 Nov 2025 | HK$326.6b | HK$122.6b | HK$6.2b | 57.2x | 53x | 2.7x |
| Wed, 22 Oct 2025 | HK$347.6b | HK$122.2b | HK$6.1b | 63.2x | 56.6x | 2.8x |
| Fri, 19 Sep 2025 | HK$380.3b | HK$122.5b | HK$6.2b | 68.4x | 61.7x | 3.1x |
| Sun, 17 Aug 2025 | HK$325.9b | HK$122.6b | HK$5.1b | 55x | 63.9x | 2.7x |
| Tue, 15 Jul 2025 | HK$242.8b | HK$115.5b | HK$4.5b | 45.6x | 53.8x | 2.1x |
| Thu, 12 Jun 2025 | HK$229.2b | HK$115.2b | HK$4.5b | 47.4x | 50.9x | 2x |
| Sat, 10 May 2025 | HK$223.4b | HK$110.9b | HK$4.2b | 61.8x | 53.4x | 2x |
| Mon, 07 Apr 2025 | HK$207.9b | HK$110.3b | HK$4.2b | 59.4x | 50x | 1.9x |
| Wed, 05 Mar 2025 | HK$222.4b | HK$103.9b | HK$3.6b | 53.6x | 61.8x | 2.1x |
| Fri, 31 Jan 2025 | HK$178.0b | HK$104.5b | HK$3.6b | 40.6x | 49.2x | 1.7x |
| Sun, 29 Dec 2024 | HK$158.9b | HK$103.3b | HK$3.6b | 37.9x | 44.4x | 1.5x |
| Tue, 26 Nov 2024 | HK$162.8b | HK$104.4b | HK$3.6b | 36.9x | 45.1x | 1.6x |
| Thu, 24 Oct 2024 | HK$174.3b | HK$104.5b | HK$3.3b | 49.6x | 52.6x | 1.7x |
| Sat, 21 Sep 2024 | HK$147.5b | HK$105.9b | HK$3.4b | 39.9x | 43.9x | 1.4x |
| Mon, 19 Aug 2024 | HK$133.7b | HK$104.5b | HK$3.0b | 36.5x | 45.1x | 1.3x |
| Wed, 17 Jul 2024 | HK$135.1b | HK$101.8b | HK$2.4b | 41.2x | 56.6x | 1.3x |
| Fri, 14 Jun 2024 | HK$156.3b | HK$102.1b | HK$2.4b | 47.7x | 65.4x | 1.5x |
| Sun, 12 May 2024 | HK$165.0b | HK$103.8b | HK$2.3b | 49.2x | 70.8x | 1.6x |
| Tue, 09 Apr 2024 | HK$144.5b | HK$103.9b | HK$2.3b | 42.9x | 61.9x | 1.4x |
| Thu, 07 Mar 2024 | HK$165.7b | HK$105.0b | -HK$1,455,442,718.25 | 55.1x | -113.9x | 1.6x |
| Sat, 03 Feb 2024 | HK$148.4b | HK$106.4b | -HK$1,474,510,706.00 | 47.5x | -100.6x | 1.4x |
| Mon, 01 Jan 2024 | HK$209.8b | HK$106.3b | -HK$1,473,286,829.00 | 64.9x | -142.4x | 2x |
| Wed, 29 Nov 2023 | HK$218.8b | HK$103.8b | -HK$1,768,881,847.00 | 88.2x | -123.7x | 2.1x |
| Fri, 27 Oct 2023 | HK$194.8b | HK$101.7b | -HK$1,734,283,216.00 | 82x | -112.3x | 1.9x |
| Sun, 24 Sep 2023 | HK$231.8b | HK$102.4b | -HK$1,675,940,225.00 | 101.3x | -138.3x | 2.3x |
| Tue, 22 Aug 2023 | HK$221.7b | HK$102.2b | -HK$2,680,359,281.00 | 74.2x | -82.7x | 2.2x |
Price to Earnings Ratio
-82.7x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 22.5x which is lower than its 3-year average PE of 101x.
- The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 12% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | -1.30% | |
| Consumer Staples | 1.15% | |
| Food and Staples Retail | 0.55% | |
| Drug Retail | -2.02% | |
| Food Retail | 5.73% | |
| Food Distributors | -1.24% | |
| Big Box Super Stores | -4.86% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6618 JD Health International | HK$39.50 | 1.4% +HK$1.8b | -35.5% | PE17.4x | |
| 2290 Lung Fung Group Holdings | HK$3.75 | 13.6% +HK$225.0m | n/a | PE7x | |
| 9886 Dingdang Health Technology Group | HK$0.77 | 5.5% +HK$50.0m | -7.2% | PS0.2x |